Tesamorelin - Axiolabs

Buy Tesamorelin 5 mg by Axiolabs at XSteroids. Tesamorelin is a GHRH analogue: a synthetic copy of the full 44 amino acid human growth hormone releasing hormone with a chemical cap at one end that slows its breakdown in the body. Axiolabs supplies it as a lyophilized 5 mg vial for reconstitution. This page covers what the peptide is, how it raises growth hormone and IGF-1, how a 5 mg vial is mixed, what human trials actually measured, and the warnings that come with the molecule.

Tesamorelin is unusual in this family because it is an approved medicine, so the evidence is stronger than for most research peptides. It is also narrower than the marketing suggests, and the label says so directly.

About Tesamorelin by Axiolabs

Tesamorelin contains all 44 amino acids of human GHRH plus a trans-3-hexenoic acid group at the N-terminus, which protects the peptide from the enzyme that would otherwise clip it within minutes. It is approved as Egrifta for HIV-associated lipodystrophy, with ATC code H01AC06, and it is injected subcutaneously.

Bioavailability by that route is low, at four percent or less, and the drug is cleared quickly: the approved label reports a mean elimination half-life of eight minutes after a 1.4 mg subcutaneous dose, while other sources cite 26 to 38 minutes. The practical point is the same either way, because the effect is measured by the daily growth hormone and IGF-1 profile rather than by how long the peptide circulates.

How Tesamorelin Works

The peptide binds the GHRH receptor on the pituitary and drives the release of the body's own growth hormone, which in turn raises IGF-1. Reduction of fat mass follows mainly from lipolysis and falling triglyceride levels, and body composition changes are described as a mix of anabolic and lipolytic mechanisms.

The human trial data are specific. A meta-analysis of four randomised trials covering 909 patients found that 2 mg daily reduced visceral fat by a mean of 21.47 square centimetres, waist circumference by 1.61 cm and trunk fat by 1.20 kg, while lean mass rose by 1.42 kg. A second meta-analysis of five trials reported visceral fat down 27.71 square centimetres and liver fat down 4.28 percent, with subcutaneous fat and body mass index unchanged. GH-related side effects and a trend towards more discontinuations were also recorded.

Tesamorelin Dosage and Reconstitution

Mixing a 5 mg vial

Add 1 to 2.5 ml of bacteriostatic water. With 1 ml the concentration is 5 mg/ml and 0.25 mg is 5 units on a U-100 syringe; with 2 ml it is 2.5 mg/ml and 0.25 mg is 10 units; with 2.5 ml it is 2 mg/ml and 0.25 mg is 12.5 units. The approved dose of 1.4 mg needs 0.28 ml at 5 mg/ml, 0.56 ml at 2.5 mg/ml or 0.7 ml at 2 mg/ml.

Approved doses and vial life

The approved product uses 1.4 mg daily in the 2 mg vial version, 2 mg daily in the original 1 mg vial, and 1.28 mg daily in the 11.6 mg vial, where one vial lasts exactly seven days. A 5 mg research vial does not cover a week at those amounts: it lasts five days at 1 mg a day, about 3.6 days at 1.4 mg and 2.5 days at 2 mg. At 0.5 mg daily it lasts 10 days, and at 0.25 mg daily it lasts 20 days.

How to Stack Tesamorelin

Because it targets visceral fat, tesamorelin is usually discussed alongside other fat loss compounds. T3 Liothyronine and Clenbutaplex 40 mcg work on metabolic rate and are commonly named in the same conversation, while AxoTropin HGH supplies growth hormone directly instead of stimulating its release.

On the peptide side, Sermorelin 5 mg is the shorter GHRH fragment and Ipamorelin 5 mg is a ghrelin receptor agonist that works through a different receptor, so the two classes are complementary rather than duplicates. A steroid base such as Testaplex Testosterone stays unchanged if one is part of the plan.

Recovery and Post-Cycle Support With Tesamorelin

Tesamorelin does not suppress testosterone production and does not require post-cycle therapy. Where it sits beside a steroid cycle, the recovery plan belongs to the anabolic compounds: Arimiplex 1 mg for estrogen control on cycle, then Tamoxiplex 20 mg or Clomiplex 50 mg afterwards.

Watch IGF-1 and fasting glucose on any run of this peptide. The approved labelling calls for IGF-1 monitoring because the long term consequences of sustained elevation are unknown, and blood work is the only way to see what a dose is doing.

Tesamorelin Side Effects and Precautions

Common effects

The most frequent adverse reactions reported in trial data are joint pain, redness and itching at the injection site, pain in the arms and legs, peripheral swelling and muscle pain. Fluid retention, carpal tunnel symptoms and impaired glucose tolerance are also listed, and the trials recorded more side effects than placebo.

Contraindications

Tesamorelin is contraindicated in people with hypothalamic or pituitary disease, after pituitary surgery or radiation, with an active malignancy, or during pregnancy. It is not indicated for weight loss management, which is stated plainly in the approved labelling.

General precautions

This material is for adult men and is not medical advice. Keep vials away from children, do not use a solution that looks cloudy, and treat rising IGF-1 or blood sugar as a reason to stop rather than to push on.

Storing and Handling Tesamorelin

Store the lyophilized vial at room temperature of 20 to 25 C in its original packaging, protected from light, and do not freeze it. Once mixed, the approved instructions keep the solution at 20 to 25 C and discard any unused portion after seven days, so plan the volume you mix around the number of doses you will actually take.

Why Buy Tesamorelin from XSteroids?

At XSteroids you buy Tesamorelin directly from the Axiolabs brand catalog, with secure checkout, US domestic shipping in 3 to 6 days and international delivery in 12 to 26 days. The 5 mg vial is on this page, and the related products below cover the fat loss partners and the cycle support that usually accompany it.